Health Science Policy Council Chair 2023 - 2025
Maarten IJzerman, MSc, PhD
Dean and Professor Cancer Health Services Research, Erasmus School of Health Policy & Management
Rotterdam, Netherlands
Past Chair 2021-2023
Newell McElwee, PharmD, MSPH
Retired HEOR Professional
Gwynedd Valley, PA, United States
Chair-Elect 2025 - 2027
Deborah Marshall, PhD, BSc
Professor, Scientific Director Value and Impact, Alberta Children's Hospital Research Institute, University of Calgary
Calgary, AB, Canada
Health Science Policy Council Members
Science/Research Committee
Co-Chairs
Reed Johnson, PhD
Professor, Duke School of Medicine, Duke Clinical Research Institute
Durham, NC, United States
Vivian Lee, PharmD, BSc
Associate Professor, The Chinese University of Hong Kong
Shatin, Hong Kong
Members
Alan Balch
CEO, Patient Advocate Foundation and National Patient Advocate Foundation
Hampton, VA, United States
Eric Barrette
Senior Director, Health Economics, Medtronic
Washington, DC, United States
J. Jaime Caro, MD
Chief Scientist, Evidera
Lincoln, MA, United States
Amanda Cole, PhD, BSc
Associate Director, Office of Health Economics
London, LON, United Kingdom
Paolo Angelo Cortesi, PhD
Assistant Professor, Research Centre on Public Health (CESP), University of Milan-Bicocca
Monza, MB, Italy
William Crown, PhD, BA, MA
Distinguished Research scientist, Brandeis University
Waltham, MA, United States
Jessica Daw, MBA, PharmD
Vice President, Pharmacy, Sentara Health Plans
Virginia Beach, VA, United States
Nancy Devlin, PhD, BA
Professor of Health Economics, University of Melbourne
Melbourne, VIC, Australia
Stephanie Earnshaw, PhD
Senior Vice President, Health Economics, RTI Health Solutions
Pittsboro, NC, United States
Gihan Elsisi, MSc, PhD, MD, BSc
Ass prof, The American University in Cairo
cairo, C, Egypt
Daniel Erku, PhD, BSc
Researcher, Management Sciences for Health
Southport, QLD, Australia
Eduardo Gonzalez-Pier, PhD
Distinguished Fellow, Center for Global Development
Cuidad de Mexico, Mexico
Jan E. Hansen, PhD, DrPH
Vice President, Evidence for Access, Genentech
South San Francisco, CA, United States
Maarten IJzerman, MSc, PhD
Dean and Professor Cancer Health Services Research, Erasmus School of Health Policy & Management
Rotterdam, Netherlands
Zoltan Kalo, PhD
Professor of Health Economics, Center for Health Technology Assessment, Semmelweis University & Syreon Research Institute
Budapest, PE, Hungary
Hemant Phatak, PhD
Amylyx Pharmaceuticals, Inc.
Needham, MA, United States
Diego Rosselli, MSc, MEd, BA, MD
Professor of Health Economics, Pontificia Universidad Javeriana
Bogota, CUN, Colombia
Task Force Review Committee
Co-Chairs
Joseph Cappelleri, MS, PhD, MPH
Executive Director of Biostatistics, Pfizer Inc
Newington, CT, United States
Mark Sculpher, MSc, PhD, BA
Professor and Director of Center for Health Economics, University of York
York, NYK, United Kingdom
Members
Suliman Alghnam, MHA
Head, Population Health, KAIMRC
Riyadh, 01, Saudi Arabia
Lou Garrison, PhD
Professor Emeritus, The Comparative Health Outcomes, Policy, and Economics (CHOICE) Institute,
Seattle, WA, United States
Isao Kamae, DrPH, MD
Project Professor, Health Policy and Technology Assessment, The University of Tokyo
Tokyo, 13, Japan
Daniel Malone, MS, RPh, PhD
Professor, University of Utah
Salt Lake City, UT, United States
Deborah Marshall, PhD, BSc
Professor, Scientific Director Value and Impact, Alberta Children's Hospital Research Institute, University of Calgary
Calgary, AB, Canada
Brian O'Rourke, PharmD
President, Brian O'Rourke Health Care Consulting Inc.
Ottawa, ON, Canada
Lotte Steuten, MSc, PhD
Deputy Chief Executive, Office of Health Economics
London, LON, United Kingdom
Praveen Thokala, PhD, MASc
SCHARR, University of Sheffield
Sheffield, United Kingdom
Adrian Towse, Mphil, MA
Senior Visiting Fellow, Office of Health Economics
London, LON, United Kingdom